Zhenghai Li
Biographic Data
| ID | 7314690 |
|---|---|
| NAME | Zhenghai Li |
| GIVEN NAMES | Zhenghai |
| FAMILY NAME | Li |
| SIGNATURE | LI Z |
| AFFILIATIONS | Guangdong Pharmaceutical University |
| ORCID | 0000-0002-2563-7636 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Sanqi Qushi formula ameliorates renal injury in experimental membranous nephropathy rats by inhibiting the MEK/ERK signaling pathway
SQQS ameliorates MN progression by inhibiting the MEK/ERK pathway, suppressing EMT, and reducing macrophage recruitment, with methylnissolin-3-O-glucoside as a key bioactive component
No prominent works on this page.
Sanqi Qushi formula ameliorates renal injury in experimental membranous nephropathy rats by inhibiting the MEK/ERK signaling pathway
SQQS ameliorates MN progression by inhibiting the MEK/ERK pathway, suppressing EMT, and reducing macrophage recruitment, with methylnissolin-3-O-glucoside as a key bioactive component
Biochemistry (1 works) · Biology (1 works) · Diabetes mellitus (1 works) · Drug-Induced Hepatotoxicity and Protection (1 works) · Endocrinology (1 works) · Kidney (1 works) · MAPK/ERK pathway (1 works) · Medicine (1 works) · Nephropathy (1 works) · Nephrotoxicity and Medicinal Plants (1 works)